Randomized Crossover Trial to Assess the Effects and Quality of Life in Patients With Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine in Combination With Nab-paclitaxel: QOLINPAC
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms QOLINPAC
- 07 Jun 2017 Biomarkers information updated
- 02 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 02 May 2017 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2017.